首页> 外文期刊>International Journal of Pharmaceutical Sciences and Research >STUDY OF ANTIATHEROSCLEROTIC ACTIVITY OF POLYHERBAL PREPARATION USING RAT AS AN EXPERIMENTAL ANIMAL MODEL
【24h】

STUDY OF ANTIATHEROSCLEROTIC ACTIVITY OF POLYHERBAL PREPARATION USING RAT AS AN EXPERIMENTAL ANIMAL MODEL

机译:以大鼠为实验动物模型的高分子制备抗动脉粥样硬化活性的研究

获取原文
           

摘要

Atherosclerosis is one of the risk factors for coronary artery disease. The present study highlights the antiatherosclerotic activity of Methanolic extract of polyherbal preparation in experimentally induced atherosclerotic rats. Atherosclerosis was developed in male Albino Wistar rats, which were randomly divided into five groups of six animals each; by feeding with high cholesterol diet for 21 days. Group 1 received normal diet. Group 2 received high cholesterol diet (HCD) which served as control. Group 5 served as standard, administered with Atorvastatin (10 mg/kg) along with HCD and Group 3 and Group 4 were administered with methanolic extract of polyherbal preparation (300 mg/kg and 600 mg/kg) along with HCD. Methanolic extract of polyherbal preparation reduced the raised serum level of total cholesterol, triglyceride , LDL ,VLDL and increased the serum HDL level as compared to the control group(High cholesterol group).There was increased HMG CoA/Mevalonate ratio in liver. There was also depletion of GSH content and increased level of SOD and MDA in liver. Methanolic extract of polyherbal preparation treated groups (300 mg/kg and 600 mg/kg) exhibited less damage to endothelial lining of aorta as compared to control group (High Cholesterol Diet),which may be attributed to hypo-cholesterolemic activity of polyherbal preparation, which may be attributed to hypocholesterolemic activity of polyherbal preparation.
机译:动脉粥样硬化是冠状动脉疾病的危险因素之一。本研究突出了多草药制剂的甲醇提取物在实验诱导的动脉粥样硬化大鼠中的抗动脉粥样硬化活性。雄性白化Wistar大鼠发展为动脉粥样硬化,将其随机分为五组,每组六只动物。通过高胆固醇饮食喂养21天。第一组接受正常饮食。第2组接受高胆固醇饮食(HCD)作为对照。第5组为标准品,与阿托伐他汀(10 mg / kg)一起与HCD一起给药,第3组和第4组与多草药制剂的甲醇提取物(300 mg / kg和600 mg / kg)一起与HCD一起给药。与对照组(高胆固醇组)相比,多草药制剂的甲醇提取物可降低血清中总胆固醇,甘油三酸酯,LDL,VLDL的升高水平,并提高血清HDL的水平。肝脏中HMG CoA /甲羟戊酸比升高。肝脏中GSH含量也减少,SOD和MDA水平升高。与对照组(高胆固醇饮食)相比,多草药制剂治疗组(300 mg / kg和600 mg / kg)的甲醇提取物对主动脉内皮层的损害较小,这可能归因于多草药制剂的降胆固醇活性,这可能归因于多草药制剂的降胆固醇活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号